CorMedix Total Assets Over Time

CRMD Stock  USD 9.68  0.17  1.73%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out CorMedix Performance and CorMedix Correlation.
For information on how to trade CorMedix Stock refer to our How to Trade CorMedix Stock guide.
  
The current year's Total Assets is expected to grow to about 86.2 M.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CorMedix. If investors know CorMedix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CorMedix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.80)
Revenue Per Share
0.212
Quarterly Revenue Growth
(0.47)
Return On Assets
(0.38)
Return On Equity
(0.65)
The market value of CorMedix is measured differently than its book value, which is the value of CorMedix that is recorded on the company's balance sheet. Investors also form their own opinion of CorMedix's value that differs from its market value or its book value, called intrinsic value, which is CorMedix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CorMedix's market value can be influenced by many factors that don't directly affect CorMedix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CorMedix's value and its price as these two are different measures arrived at by different means. Investors typically determine if CorMedix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CorMedix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Total Assets Analysis

Compare CorMedix and related stocks such as Tarsus Pharmaceuticals, LianBio ADR, and Aldeyra Total Assets Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On EquityOperating Cycle
Cash Conversion Cycle
201020112012201320142015201620172018201920202021202220232024
TARS2.4 M2.4 M2.4 M2.4 M2.4 M2.4 M2.4 M2.4 M2.4 M58.3 M172 M178.9 M227.9 M265.5 M165.9 M
ALDX258.9 K258.9 KM3.7 M8.8 M28.2 M25.2 M44.2 M95.1 M75.5 M83.4 M233.1 M181.3 M148.3 M78.6 M
TVTX4.8 K3.9 K2.4 M20.5 M135.5 M512.4 M525.3 M520.3 M709.2 M604.8 M607.4 M776.6 M672.6 M788.9 M461.7 M
ETON13.4 M13.4 M13.4 M13.4 M13.4 M13.4 M13.4 M13.4 M28.3 M17.1 M26.3 M27.5 M25 M31.7 M26.6 M
PGEN114.8 M114.8 M151.6 M469.5 M576.3 M982 M949.1 M846.9 M716.2 M455.8 M314.6 M359.9 M216 M151 M143.5 M
SGMO539 K87.3 M82.5 M140.8 M243.2 M217.2 M157.9 M286.7 M590.4 M637.5 M938.5 M721.9 M562.5 M165.3 M218.1 M
APTO7.7 M2.1 M648.2 KM28.5 M15.3 M8.6 M12 M16.9 M100.5 M126.3 M82.5 M51 M13 M12.3 M
INBX17.2 M17.2 M17.2 M17.2 M17.2 M17.2 M17.2 M17.2 M10 M26.5 M143.7 M150.4 M290.9 M307.9 M323.3 M
CELC5.3 M5.3 M5.3 M5.3 M5.3 M5.3 M6.1 M32 M26 M20.3 M13 M85.9 M175.7 M191.2 M200.8 M
ELVN10.2 M10.2 M10.2 M10.2 M10.2 M10.2 M10.2 M10.2 M7.7 M33.3 M131 M113.3 M83.3 M271.9 M285.5 M
REPL22.8 M22.8 M22.8 M22.8 M22.8 M22.8 M22.8 M65.2 M154.3 M234.1 M543.1 M461.2 M646.6 M487.7 M359.6 M
NVCT6.7 M6.7 M6.7 M6.7 M6.7 M6.7 M6.7 M6.7 M6.7 M6.7 M6.7 M6.7 M20.4 M19.2 M14.5 M
LYRA25.4 M25.4 M25.4 M25.4 M25.4 M25.4 M25.4 M25.4 M25.4 M15 M80.8 M54.9 M110 M142.6 M78.6 M
KRON12.6 M12.6 M12.6 M12.6 M12.6 M12.6 M12.6 M12.6 M12.6 M102.7 M512 M391.5 M294.9 M213.3 M279.9 M
GOSS60 K60 K60 K60 K60 K60 K60 K445 K239.4 M426.6 M539.4 M343.7 M272.4 M311.9 M293.4 M
CNTB372.6 M372.6 M372.6 M372.6 M372.6 M372.6 M372.6 M372.6 M372.6 M372.6 M166.2 M291.4 M177 M125.9 M181.3 M
ABOS7.3 M7.3 M7.3 M7.3 M7.3 M7.3 M7.3 M7.3 M7.3 M7.3 M44.4 M230.3 M196.6 M310.1 M173.5 M
NUVB121 M121 M121 M121 M121 M121 M121 M121 M121 M121 M221.8 M776.2 M672.1 M621.5 M530.8 M
ELDN12 M12 M12 M32.3 M107.7 M68 M29.8 M20.9 M17 M10.9 M197.2 M170.5 M92.8 M125.9 M81.1 M

CorMedix and related stocks such as Tarsus Pharmaceuticals, LianBio ADR, and Aldeyra Total Assets description

Total assets refers to the total amount of CorMedix assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in CorMedix books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

My Equities

My Current Equities and Potential Positions

CorMedix
CRMD
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
LocationNew Jersey; U.S.A
ExchangeNASDAQ Exchange
USD 9.68
When determining whether CorMedix is a strong investment it is important to analyze CorMedix's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CorMedix's future performance. For an informed investment choice regarding CorMedix Stock, refer to the following important reports:
Check out CorMedix Performance and CorMedix Correlation.
For information on how to trade CorMedix Stock refer to our How to Trade CorMedix Stock guide.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
CorMedix technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of CorMedix technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of CorMedix trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...